Cargando…
Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Patient Experience after 11 Years
The deep brain stimulation (DBS) in early-stage Parkinson’s disease (PD) pilot trial began more than a decade ago and remains the only investigation of DBS in mildly symptomatic patients. Patients completed therapeutic washouts biannually for two years, outpatient assessments through five years, and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220916/ https://www.ncbi.nlm.nih.gov/pubmed/35741651 http://dx.doi.org/10.3390/brainsci12060766 |
_version_ | 1784732492834537472 |
---|---|
author | Stoehr, Kaitlyn Pazira, Kian Bonnet, Kemberlee Schlundt, David Charles, David Hacker, Mallory |
author_facet | Stoehr, Kaitlyn Pazira, Kian Bonnet, Kemberlee Schlundt, David Charles, David Hacker, Mallory |
author_sort | Stoehr, Kaitlyn |
collection | PubMed |
description | The deep brain stimulation (DBS) in early-stage Parkinson’s disease (PD) pilot trial began more than a decade ago and remains the only investigation of DBS in mildly symptomatic patients. Patients completed therapeutic washouts biannually for two years, outpatient assessments through five years, and a longitudinal washout assessment after 11 years. Here, the patient experience of participating in the early DBS pilot trial is described. Semi-structured interviews were audio-recorded and transcribed. Transcripts were coded, analyzed using an iterative inductive-deductive approach, and used to develop a conceptual framework. Ten participants (n = 6 early optimal drug therapy (ODT), n = 4 early DBS + ODT) were interviewed. Motivations for participation included benefit to future PD patients and potential personal benefit, while hesitations included risk of surgical complications. While early ODT patients who received standard-of-care DBS described significant changes in their functional capacities after surgery, early DBS patients described a maintenance of quality of life that made PD less impactful over an extended period. Patients expressed high satisfaction with trial participation and early DBS. This study suggests that the PD experience with early DBS may notably differ from standard-of-care DBS. The FDA has approved the conduct of a pivotal clinical trial evaluating DBS in early-stage PD (IDEG050016). |
format | Online Article Text |
id | pubmed-9220916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92209162022-06-24 Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Patient Experience after 11 Years Stoehr, Kaitlyn Pazira, Kian Bonnet, Kemberlee Schlundt, David Charles, David Hacker, Mallory Brain Sci Article The deep brain stimulation (DBS) in early-stage Parkinson’s disease (PD) pilot trial began more than a decade ago and remains the only investigation of DBS in mildly symptomatic patients. Patients completed therapeutic washouts biannually for two years, outpatient assessments through five years, and a longitudinal washout assessment after 11 years. Here, the patient experience of participating in the early DBS pilot trial is described. Semi-structured interviews were audio-recorded and transcribed. Transcripts were coded, analyzed using an iterative inductive-deductive approach, and used to develop a conceptual framework. Ten participants (n = 6 early optimal drug therapy (ODT), n = 4 early DBS + ODT) were interviewed. Motivations for participation included benefit to future PD patients and potential personal benefit, while hesitations included risk of surgical complications. While early ODT patients who received standard-of-care DBS described significant changes in their functional capacities after surgery, early DBS patients described a maintenance of quality of life that made PD less impactful over an extended period. Patients expressed high satisfaction with trial participation and early DBS. This study suggests that the PD experience with early DBS may notably differ from standard-of-care DBS. The FDA has approved the conduct of a pivotal clinical trial evaluating DBS in early-stage PD (IDEG050016). MDPI 2022-06-11 /pmc/articles/PMC9220916/ /pubmed/35741651 http://dx.doi.org/10.3390/brainsci12060766 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Stoehr, Kaitlyn Pazira, Kian Bonnet, Kemberlee Schlundt, David Charles, David Hacker, Mallory Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Patient Experience after 11 Years |
title | Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Patient Experience after 11 Years |
title_full | Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Patient Experience after 11 Years |
title_fullStr | Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Patient Experience after 11 Years |
title_full_unstemmed | Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Patient Experience after 11 Years |
title_short | Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Patient Experience after 11 Years |
title_sort | deep brain stimulation in early-stage parkinson’s disease: patient experience after 11 years |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220916/ https://www.ncbi.nlm.nih.gov/pubmed/35741651 http://dx.doi.org/10.3390/brainsci12060766 |
work_keys_str_mv | AT stoehrkaitlyn deepbrainstimulationinearlystageparkinsonsdiseasepatientexperienceafter11years AT pazirakian deepbrainstimulationinearlystageparkinsonsdiseasepatientexperienceafter11years AT bonnetkemberlee deepbrainstimulationinearlystageparkinsonsdiseasepatientexperienceafter11years AT schlundtdavid deepbrainstimulationinearlystageparkinsonsdiseasepatientexperienceafter11years AT charlesdavid deepbrainstimulationinearlystageparkinsonsdiseasepatientexperienceafter11years AT hackermallory deepbrainstimulationinearlystageparkinsonsdiseasepatientexperienceafter11years |